Targeting the coronavirus nucleocapsid protein through GSK-3 inhibition (Q108782646)

18

object named as

Vaithilingaraja Arumugaswami

0 references

author name string

Xiaolei Liu

1

0 references

Anurag Verma

2

0 references

Gustavo Garcia

3

0 references

Holly Ramage

4

0 references

Anastasia Lucas

5

0 references

Rebecca L. Myers

6

0 references

Jacob J. Michaelson

7

0 references

William Coryell

8

0 references

Arvind Kumar

9

0 references

Alexander W. Charney

10

0 references

Marcelo G. Kazanietz

11

0 references

Daniel J. Rader

12

0 references

Wade H. Berrettini

14

0 references

David C. Schultz

15

0 references

Sara Cherry

16

0 references

Robert Damoiseaux

17

0 references

Peter S. Klein

Proceedings of the National Academy of Sciences of the United States of America

19

0 references

publication date

30 September 2021

0 references

published in

0 references

volume

118

0 references

issue

42

0 references

page(s)

e2113401118

0 references

copyright license

Creative Commons Attribution 4.0 International

start time

30 September 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Lithium's antiviral effects: a potential drug for CoViD-19 disease?

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Lithium as a candidate treatment for COVID-19: Promises and pitfalls

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Actionable Cytopathogenic Host Responses of Human Alveolar Type 2 Cells to SARS-CoV-2

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

GSK-3: tricks of the trade for a multi-tasking kinase

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Lithium chloride inhibits the coronavirus infectious bronchitis virus in cell culture

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Action mechanisms of lithium chloride on cell infection by transmissible gastroenteritis coronavirus

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

The cellular interactome of the coronavirus infectious bronchitis virus nucleocapsid protein and functional implications for virus biology

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Phosphorylation and subcellular localization of transmissible gastroenteritis virus nucleocapsid protein in infected cells

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Glycogen synthase kinase-3 regulates the phosphorylation of severe acute respiratory syndrome coronavirus nucleocapsid protein and viral replication

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

A molecular mechanism for the effect of lithium on development

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

The SARS-CoV nucleocapsid protein: a protein with multifarious activities

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Identification of mouse hepatitis coronavirus A59 nucleocapsid protein phosphorylation sites

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

The SARS coronavirus nucleocapsid protein--forms and functions.

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection.

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

The severe acute respiratory syndrome coronavirus nucleocapsid protein is phosphorylated and localizes in the cytoplasm by 14-3-3-mediated translocation

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Lithium and valproic acid: parallels and contrasts in diverse signaling contexts

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Antiviral effect of lithium chloride on porcine epidemic diarrhea virus in vitro.

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Stressed and Inflamed, Can GSK3 Be Blamed?

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Activation of the Wnt signaling pathway: a molecular mechanism for lithium action

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Improved vectors and genome-wide libraries for CRISPR screening

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

A contemporary view of coronavirus transcription.

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Phosphorylation of the arginine/serine dipeptide-rich motif of the severe acute respiratory syndrome coronavirus nucleocapsid protein modulates its multimerization, translation inhibitory activity and cellular localization

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Nucleocapsid phosphorylation and RNA helicase DDX1 recruitment enables coronavirus transition from discontinuous to continuous transcription

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Mutual reinforcement between telomere capping and canonical Wnt signalling in the intestinal stem cell niche

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Glycogen synthase kinase-3 is essential for β-arrestin-2 complex formation and lithium-sensitive behaviors in mice

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Phosphoproteomics reveals that glycogen synthase kinase-3 phosphorylates multiple splicing factors and is associated with alternative splicing

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Clinical use of lithium salts: guide for users and prescribers

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Lithium regulates glycogen synthase kinase-3beta in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder.

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

The central role of the propensity score in observational studies for causal effects

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Replication

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Post-transcriptional Regulation of De Novo Lipogenesis by mTORC1-S6K1-SRPK2 Signaling.

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

The Global Phosphorylation Landscape of SARS-CoV-2 Infection

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Glycogen synthase kinase-3 and alternative splicing

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Respiratory infections during lithium and valproate medication: a within-individual prospective study of 50,000 patients with bipolar disorder

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Ordered multisite protein phosphorylation. Analysis of glycogen synthase kinase 3 action using model peptide substrates

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Lithium and Therapeutic Targeting of GSK-3

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118

Apc-mutant cells act as supercompetitors in intestinal tumour initiation

3 October 2021

1 reference

https://api.crossref.org/works/10.1073/pnas.2113401118